Form 4: DuPont Director Amy G. Brady Acquires Shares Through Dividend Reinvestment

Sentiment:

SEC Form 4 Filing


Director Amy G. Brady acquired 99.3641 shares of DuPont de Nemours, Inc. common stock through dividend reinvestment at a price of $81.77 per share.

Summary

  • On February 28, 2025, Amy G. Brady, a director of DuPont de Nemours, Inc., acquired 99.3641 shares of common stock.
  • The acquisition was made through dividend reinvestment at a price of $81.77 per share.
  • Following the transaction, Brady directly owns 16,061.9306 shares of DuPont common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a routine transaction (dividend reinvestment) by a company director, indicating a standard course of action rather than a significant event driving strong positive or negative sentiment.

Positives

  • The acquisition of shares by a director through dividend reinvestment can be seen as a positive signal, indicating confidence in the company's future.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. Dividend reinvestment is a common way for insiders to increase their holdings without making open market purchases.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders, as it involves a small number of shares acquired through dividend reinvestment.

Key Dates

DateDescription
02/28/2025Date of transaction: Amy G. Brady acquired shares of DuPont common stock through dividend reinvestment.
03/04/2025Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.